CSGP vs LAB · P/E 484, rev $2.74B vs rev $174.4M
CoStar Group Inc (CSGP) versus Standard Biotools Inc (LAB) — a side-by-side from cached financials, not a winner call.
CoStar Group Inc (CSGP) is a real estate services company listed on US.
Standard Biotools Inc (LAB) is a medical devices company listed on NASDAQ.
Latest reported CSGP revenue for 2024-12-31 was $2.74B. Net income was $138.7M. Revenue was up 11.5% from 2023-12-31 to 2024-12-31. CSGP currently screens at market cap $13.84B and trailing P/E 484.1.
Latest reported LAB revenue for 2024-12-31 was $174.4M. Net income was -$138.9M. Revenue was up 64.0% from 2023-12-31 to 2024-12-31. LAB currently screens at market cap $317.1M.
CSGP currently screens at market cap $13.84B and trailing P/E 484.1. LAB currently screens at market cap $317.1M.
Not investment advice. Open the CSGP and LAB stock pages for the full models.
Not investment advice.